Abstract
The major histocompatibility complex (MHC) genes are highly polymorphic (sequence-level variation) among different ethnic population (Black, Caucasoid, Oriental, Hispanic, mixed race, Pacific Islander, American Indian, and Australian aboriginal). The sequences for MHC genes among the population are known, named, and made available at the IMGT/HLA databases. The current database update consists of more than 18,000 human leukocyte antigen (HLA) alleles as on early 2018. The binding of short peptides (8–20 residues long) to MHC molecules has an important role in T-cell-mediated immune response. The binding prediction of peptides to MHC is challenging due to its sequence polymorphism among ethnic groups. MHC-peptide binding prediction in the design of T-cell epitopes using T-EPITOPE Designer for short peptide vaccine development is discussed. However, it has been suggested that majority of alleles can be covered within few HLA supertypes, where different members of a supertype bind similar peptides, yet exhibiting distinct repertoires. The grouping of HLA alleles into different categories of supertypes has profound use in the understanding of antigenic peptide selection, degeneration, and discrimination during T-cell-mediated immune response. This phenomenon is highly useful in the identification of super antigens specific to several known alleles as vaccine candidates with broad immunity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Altman JD, Moss PA, Goulder PJR et al (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274:94–96
Altuvia Y, Schueler O, Margalit H (1995) Ranking potential binding peptides to MHC molecules by a computational threading approach. J Mol Biol 249:244–250
Altuvia Y, Sette A, Sidney J et al (1997) A structure-based algorithm to predict potential binding peptides to MHC molecules with hydrophobic binding pockets. Hum Immunol 58:1–11
Batalia MA, Collins EJ (1997) Peptide binding by class I and class II MHC molecules. Biopolymers 43:281–302
Bhasin M, Raghava GPS (2003) Prediction of promiscuous and high-affinity mutated MHC binders. Hybrid Hybridomics 22:229–234
Bhasin M, Raghava GPS (2004a) Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22:3195–3201
Bhasin M, Raghava GPS (2004b) SVM based method for predicting HLA-DRB1 binding peptides in an antigen sequence. Bioinformatics 20:421–423
Bhasin M, Raghava GPS (2006) A hybrid approach for predicting promiscuous MHC class I restricted T cell epitopes. J Biosci 32:31–42
Bjorkman PJ, Saper MA, Samraoui B et al (1987a) Structure of the human class I histocompatibility antigen, HLA-A2. Nature 329:506–512
Bjorkman PJ, Saper MA, Samraoui B et al (1987b) The foreign antigen-binding site and T cell recognition regions of class I histocompatibility antigens. Nature 329:512–518
Bodmer JG, Marsh SGE, Albert ED et al (1999) Nomenclature for factors of the HLA system. Tissue Antigens 53:407–446
von Boehmer H (1992) Thymic selection: a matter of life and death. Immunol Today 13:454–458
Bork P, Holm L, Sander C (1994) The immunoglobulin fold. Structural classification, sequence patterns and common core. J Mol Biol 242:309–320
Brown JH, Jardetzky TS, Gorga JC et al (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33–39
Brusic V, Rudy G, Harrison LC (1998) MHCPEP, a database of MHC-binding peptides: update 1997. Nucleic Acids Res 26:368–371
Buus S (1999) Description and prediction of peptide-MHC binding: the ‘human MHC project’. Curr Opin Immunol 11:209–213
Chelvanayagam G (1996) A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics 45:15–26
Colbert RA, Rowland-Jones SL, McMichael AJ et al (1994) Differences in peptide presentation between B27 subtypes: the importance of the P1 side chain in maintaining high affinity peptide binding to B*2703. Immunity 1:121–130
Collins EJ, Garboczi DN, Karpusas MN et al (1995) The three-dimensional structure of a class I major histocompatibility complex molecule missing the alpha 3 domain of the heavy chain. Proc Natl Acad Sci U S A 92:1218–1221
Cook JR, Myers NB, Hansen TH (1996) The mechanisms of peptide exchange and beta 2-microglobulin exchange on cell surface Ld and Kb molecules are noncooperative. J Immunol 157:2256–2261
Corradin G, Demotz S (1997) Peptide-MHC complexes assembled following multiple pathways: an opportunity for the design of vaccines and therapeutic molecules. Hum Immunol 54:137–147
Cresswell P (1994) Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12:259–293
Dawkins R, Leelayuwat C, Gaudieri S et al (1999) Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol Rev 167:275–304
Del Guercio MF, Sidney J, Hermanson G et al (1995) Binding of a peptide antigen to multiple HLA alleles allows definition of an A2-like supertype. J Immunol 154:685–693
Den Haan JM, Meadows LM, Wang W et al (1998) The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science 279:1054–1057
Dönnes P, Elofsson A (2002) Prediction of MHC class I binding peptides using SVMHC. BMC Bioinformatics 3:25
Doytchinova IA, Guan P, Flower DR (2004) Identifying human MHC supertypes using bioinformatics methods. J Immunol 172:4314–4323
Eckels DD (2000) MHC: function and implication on vaccine development. Vox Sang 78(Suppl 2):265–267
Falk K, Rotzschke O, Rammensee HG (1990) Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348:248–251
Guo HC, Jardetzky TS, Garrett TP et al (1992) Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle. Nature 360:364–366
Hakenberg J, Nussbaum A, Schild H et al (2003) MAPPP—MHC-I antigenic peptide processing prediction. Appl Bioinforma 2:155–158
Hattotuwagama CK, Guan P, Doytchinova IA et al (2004) Quantitative online prediction of peptide binding to the major histocompatibility complex. J Mol Graph Model 22:195–207
Honeyman MC, Brusic V, Stone NL et al (1998) Neural network-based prediction of candidate T-cell epitopes. Nat Biotechnol 16:966–969
Jackson MR, Peterson PA (1993) Assembly and intracellular transport of MHC class I molecules. Annu Rev Cell Biol 9:207–235
Jardetzky TS, Lane WS, Robinson RA et al (1991) Identification of self peptides bound to purified HLA-B27. Nature 353:326–329
Jardetzky TS, Brown JH, Gorga JC et al (1994) Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368:711–718
Jung C, Kalbus M, Fleckenstein B, Melms A et al (1998) New ligands for HLA DRB1*0301 by random selection of favorable amino acids ranked by competition studies with undecapeptide amide sublibraries. J Immunol Methods 219:139–149
Kangueane P, Sakharkar MK (2007a) Grouping of class I HLA alleles using electrostatic distribution maps of the peptide binding grooves. Methods Mol Biol 409:175–181
Kangueane P, Sakharkar MK (2007b) Structural basis for HLA-A2 supertypes. Methods Mol Biol 409:155–162
Kangueane P, Sakharkar MK, Kolatkar PR et al (2001) Towards the MHC-peptide combinatorics. Hum Immunol 62:539–556
Kangueane P, Sakharkar MK, Rajaseger G et al (2005) A framework to sub-type HLA supertypes. Front Biosci 10:879–886
Klein J (1986) Natural history of the major histocompatibility complex. Wiley, New York
Lee C, McConnell HM (1995) A general model of invariant chain association with class II major histocompatibility complex proteins. Proc Natl Acad Sci U S A 92:8269–8273
Lehmann-Grube F, Dralle H, Utermohlen O et al (1994) MHC class I molecule-restricted presentation of viral antigen in beta 2-microglobulin-deficient mice. J Immunol 153:595–603
Lund O, Nielsen M, Kesmir C et al (2004) Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics 55:797–810
Madden DR, Gorga JC, Strominger JL, Wiley DC (1992) The three-dimensional structure of HLA-B27 at 2.1 A resolution suggests a general mechanism for tight peptide binding to MHC. Cell 70(6):1035–1048
Madden DR, Gorga JC, Strominger JL et al (1991) The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation. Nature 353:321–325
Madden DR, Garboczi DN, Wiley DC (1993) The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75:693–708
Mamitsuka H (1998) Predicting peptides that bind to MHC molecules using supervised learning of hidden Markov models. Proteins 33:460–474
Mazza G, Housset D, Piras C et al (1998) Glimpses at the recognition of peptide/MHC complexes by T-cell antigen receptors. Immunol Rev 163:187–196
McDevitt HO (2000) Discovering the role of the major histocompatibility complex in the immune response. Annu Rev Immunol 18:1–17
Milik M, Sauer D, Brunmark AP et al (1998) Application of an artificial neural network to predict specific class I MHC binding peptide sequences. Nat Biotechnol 16:753–756
Murthy VL, Stern LJ (1997) The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 5:1385–1396
Neefjes JJ, Momburg F (1993) Cell biology of antigen presentation. Curr Opin Immunol 5:27–34
Nielsen M, Lundegaard C, Worning P et al (2004) Improved prediction of MHC class I and class II epitopes using a novel Gibbs sampling approach. Bioinformatics 20:1388–1397
Ortmann B, Androlewicz MJ, Cresswell P (1994) MHC class I/beta 2-microglobulin complexes associate with TAP transporters before peptide binding. Nature 368:864–867
Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152:163–175
Peters PJ, Raposo G, Neefjes JJ et al (1995) Major histocompatibility complex class II compartments in human B lymphoblastoid cells are distinct from early endosomes. J Exp Med 182:325–334
Peters B, Tong W, Sidney J et al (2003) Examining the independent binding assumption for binding of peptide epitopes to MHC-I molecules. Bioinformatics 19:1765–1772
Pogue RR, Eron J, Frelinger JA et al (1995) Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc Natl Acad Sci U S A 92:8166–8170
Rammensee HG, Falk K, Rotzschke O (1993) Peptides naturally presented by MHC class I molecules. Annu Rev Immunol 11:213–244
Rammensee HG, Friede T, Stevanoviic S (1995) MHC ligands and peptide motifs: first listing. Immunogenetics 41:178–228
Rammensee H, Bachmann J, Emmerich NN et al (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213–219
Reche PA, Reinherz EL (2003) Sequence variability analysis of human class-I and class-II MHC molecules: functional and structural correlates of amino acid polymorphisms. J Mol Biol 331:623–641
Robinson J, Waller MJ, Parham P et al (2003) IMGT/HLA and IMGT/MHC: sequence databases for the study of the major histocompatibility complex. Nucleic Acids Res 31:311–314
Rock KL, Gramm C, Rothstein L et al (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78:761–771
Rudensky AY, Maric M, Eastman S et al (1994) Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity 1:585–594
Ruppert J, Sidney J, Celis E et al (1993) Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell 74:929–937
Sathiamurthy M, Hickman HD, Cavett JW et al (2003) Population of the HLA ligand database. Tissue Antigens 61:12–19
Schafer JR, Jesdale BM, George JA et al (1998) Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix. Vaccine 16:1880–1884
Schueler-Furman O, Elber R, Margalit H (1998) Knowledge-based structure prediction of MHC class I bound peptides: a study of 23 complexes. Fold Des 3:549–564
Sette A, Sidney J (1998) HLA supertypes and supermotifs—a functional perspective on HLA polymorphism. Curr Opin Immunol 10:478–482
Sette A, Vitiello A, Reherman B et al (1994) The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol 153:5586–5592
Sette A, Newman M, Livingston B et al (2002) Optimizing vaccine design for cellular processing, MHC binding and TCR recognition. Tissue Antigens 59:443–451
Sidney J, Southwood S, Pasquetto V et al (2003) Simultaneous prediction of binding capacity for multiple molecules of the HLA B44 supertype. J Immunol 171:5964–5974
Singh H, Raghava GPS (2001) ProPred: prediction of HLA-DR binding sites. Bioinformatics 17:1236–1237
Singh H, Raghava GPS (2003) ProPred1: prediction of promiscuous MHC class-I binding sites. Bioinformatics 19:1009–10014
Stern LJ, Brown JH, Jardetzky TS et al (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368:215–221
Suh WK, Cohen-Doyle MF, Fruh K et al (1994) Interaction of MHC class I molecules with the transporter associated with antigen processing. Science 264:1322–1326
The MHC Sequencing Consortium (1999) The complete sequence and gene map of a human major histocompatibility complex. Nature 401:921–923
Tiwari JL, Terasaki PI (1985) HLA and disease associations. Springer, Berlin
Townsend A, Elliott T, Cerundolo V et al (1990) Assembly of MHC class I molecules analyzed in vitro. Cell 62:285–295
Turner S, Ellexson ME, Hickman HD et al (1998) Sequence-based typing provides a new look at HLA-C diversity. J Immunol 161:1406–1413
Uebel S, Tampe R (1999) Specificity of the proteasome and the TAP transporter. Curr Opin Immunol 11:203–208
Venkatarajan MS, Braun W (2001) New quantitative descriptor of amino acids based on multi-dimensional scaling of a large number of physical-chemical properties. J Mol Model 7:445–456
Wilke M, Pool J, den Haan JMM et al (1998) Genomic identification of the minor histocompatibility antigen HA-1 locus by allele-specific PCR. Tissue Antigens 52:312–317
Yewdell JW, Reits E, Neefjes J (2003) Making sense of mass destruction—quantitating MHC class I antigen presentation. Nat Rev Immunol 3:952–961
Zhang C, Anderson A, DeLisi C (1998) Structural principles that govern the peptide binding motifs of class I MHC molecules. J Mol Biol 281:929–947
Zhao B, Mathura VS, Rajaseger G et al (2003a) A novel MHCp binding prediction model. Hum Immunol 64:1123–1143
Zhao B, Png AEH, Ren EC et al (2003b) Compression of functional space in HLA-A sequence diversity. Hum Immunol 64:718–728
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Kangueane, P. (2018). MHC Informatics to Peptide Vaccine Design. In: Bioinformation Discovery. Springer, Cham. https://doi.org/10.1007/978-3-319-95327-4_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-95327-4_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95326-7
Online ISBN: 978-3-319-95327-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)